Heart Failure

    Written by:
    Marina Shkayeva

    Fact-checked

    by:

    Rob Stenstrom, Brady Holmer
    Last Updated: October 13, 2024

    Heart failure (HF), also known as congestive heart failure, is a progressive condition that occurs when the heart cannot pump enough blood to oxygenate the tissues in the brain and body. It is typically caused by other heart conditions that change the heart's structure and function. Heart failure is common, and is the leading cause of hospitalization for patients over age 65 in the U.S.

    4 references on this page
    170,166 participants in 21 trials and 12 meta-analyses

    Overview

    Examine Database: Heart Failure

    Research FeedRead all studies

    Frequently asked questions

    Examine Database References

    1. Exercise Capacity (with Heart Conditions) - Zeng XH, Zeng XJ, Li YYEfficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathyAm J Cardiol.(2003 Jul 15)
    2. Exercise Capacity (with Heart Conditions) - Omran H, Illien S, MacCarter D, St Cyr J, Lüderitz BD-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility studyEur J Heart Fail.(2003 Oct)
    3. Exercise Capacity (with Heart Conditions) - Pliml W, von Arnim T, Stäblein A, Hofmann H, Zimmer HG, Erdmann EEffects of ribose on exercise-induced ischaemia in stable coronary artery disease.Lancet.(1992-Aug-29)
    4. Quality of Life - Pierce JD, Shen Q, Mahoney DE, Rahman F, Krueger KJ, Diaz FJ, Clark L, Smith C, Vacek J, Hiebert JBEffects of Ubiquinol and/or D-ribose in Patients With Heart Failure With Preserved Ejection Fraction.Am J Cardiol.(2022 Aug 1)
    5. Exercise Capacity (with Heart Conditions) - Juan José Orozco-Gutiérrez, Lilia Castillo-Martínez, Arturo Orea-Tejeda, Oscar Vázquez-Díaz, Adrián Valdespino-Trejo, René Narváez-David, Candace Keirns-Davis, Olín Carrasco-Ortiz, Adolfo Navarro-Navarro, Rocío Sánchez-SantillánEffect of L-arginine or L-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fractionCardiol J.(2010)
    6. Left Ventricular Ejection Fraction - Karla Balderas-Munoz, Lilia Castillo-Martínez, Arturo Orea-Tejeda, Oscar Infante-Vázquez, Marcelo Utrera-Lagunas, Raúl Martínez-Memije, Candace Keirns-Davis, Bryan Becerra-Luna, Gabriela Sánchez-VidalImprovement of ventricular function in systolic heart failure patients with oral L-citrulline supplementationCardiol J.(2012)
    7. Exercise Capacity (with Heart Conditions) - Beyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MAEffect of taurine supplementation on exercise capacity of patients with heart failureJ Cardiol.(2011 May)
    8. Exercise Capacity (with Heart Conditions) - K Adarsh, H Kaur, V MohanCoenzyme Q10 (CoQ10) in isolated diastolic heart failure in hypertrophic cardiomyopathy (HCM)Biofactors.(2008)
    9. Exercise Capacity (with Heart Conditions) - Fumagalli S, Fattirolli F, Guarducci L, Cellai T, Baldasseroni S, Tarantini F, Di Bari M, Masotti G, Marchionni NCoenzyme Q10 terclatrate and creatine in chronic heart failure: a randomized, placebo-controlled, double-blind studyClin Cardiol.(2011 Apr)
    10. Exercise Capacity (with Heart Conditions) - Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GPCoenzyme Q10 and exercise training in chronic heart failureEur Heart J.(2006 Nov)
    11. Exercise Capacity - Lei L, Liu YEfficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.BMC Cardiovasc Disord.(2017-Jul-24)
    12. Exercise Capacity (with Heart Conditions) - Kuethe F, Krack A, Richartz BM, Figulla HRCreatine supplementation improves muscle strength in patients with congestive heart failurePharmazie.(2006 Mar)
    13. Exercise Capacity (with Heart Conditions) - Basford JR, Oh JK, Allison TG, Sheffield CG, Manahan BG, Hodge DO, Tajik AJ, Rodeheffer RJ, Tei CSafety, acceptance, and physiologic effects of sauna bathing in people with chronic heart failure: a pilot report.Arch Phys Med Rehabil.(2009-Jan)
    14. Left Atrial Dimension - Miyata M, Kihara T, Kubozono T, Ikeda Y, Shinsato T, Izumi T, Matsuzaki M, Yamaguchi T, Kasanuki H, Daida H, Nagayama M, Nishigami K, Hirata K, Kihara K, Tei CBeneficial effects of Waon therapy on patients with chronic heart failure: results of a prospective multicenter study.J Cardiol.(2008-Oct)
    15. Left Atrial Dimension - Kihara T, Biro S, Ikeda Y, Fukudome T, Shinsato T, Masuda A, Miyata M, Hamasaki S, Otsuji Y, Minagoe S, Akiba S, Tei CEffects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure.Circ J.(2004-Dec)
    16. Left Ventricular Ejection Fraction - Kuwahata S, Miyata M, Fujita S, Kubozono T, Shinsato T, Ikeda Y, Hamasaki S, Kuwaki T, Tei CImprovement of autonomic nervous activity by Waon therapy in patients with chronic heart failure.J Cardiol.(2011-Jan)
    17. Left Ventricular Ejection Fraction - Fujita S, Ikeda Y, Miyata M, Shinsato T, Kubozono T, Kuwahata S, Hamada N, Miyauchi T, Yamaguchi T, Torii H, Hamasaki S, Tei CEffect of Waon therapy on oxidative stress in chronic heart failure.Circ J.(2011)
    18. Brain Natriuretic Peptide - Tei C, Imamura T, Kinugawa K, Inoue T, Masuyama T, Inoue H, Noike H, Muramatsu T, Takeishi Y, Saku K, Harada K, Daida H, Kobayashi Y, Hagiwara N, Nagayama M, Momomura S, Yonezawa K, Ito H, Gojo S, Akaishi M, Miyata M, Ohishi M, Waon Therapy for Managing Chronic Heart Failure　- Results From a Multicenter Prospective Randomized WAON-CHF Study.Circ J.(2016)
    19. Brain Natriuretic Peptide - Ichiki T, Burnett JC, Scott CG, Heublein DM, Miyata M, Kinugawa K, Inoue T, Tei C, Neurohumoral Modulation During Waon Therapy in Chronic Heart Failure　- Subanalysis of Waon-CHF Study.Circ J.(2017-Apr-25)
    20. Depression Symptoms - Masuda A, Nakazato M, Kihara T, Minagoe S, Tei CRepeated thermal therapy diminishes appetite loss and subjective complaints in mildly depressed patients.Psychosom Med.(2005)
    21. Quality of Life - Mei Z, Chen J, Luo S, Jin L, Liu Q, Chen YComparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials.Pharmacol Res.(2022-Aug)
    22. Exercise Capacity - Hamza M, Sattar Y, Manasrah N, Patel NN, Rashdi A, Khanal R, Naveed H, Zafar M, Khan AM, Alharbi A, Aamir M, Gonuguntla K, Raina S, Balla SMeta-Analysis of Efficacy and Safety of Intravenous Iron in Patients With Iron Deficiency and Heart Failure With Reduced Ejection Fraction.Am J Cardiol.(2023-Sep-01)
    23. Left Ventricular Ejection Fraction - Hamed M, Elseidy SA, Ahmed A, Thakker R, Mansoor H, Khalili H, Mohsen A, Mamas MA, Banerjee S, Kumbhani DJ, Elgendy IY, Elbadawi AIntravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials.Heliyon.(2023-Jun)
    24. Exercise Capacity - Long W, Liao H, Liu Q, Ning Y, Wu T, Kang J, Liu J, Xian S, Yang ZEffect of nitrate treatment on functional capacity and exercise time in patients with heart failure: a systematic review and meta-analysis.J Int Med Res.(2020 Aug)
    25. Left Ventricular Diastolic Dimension - Chen X, Zhao W, Zhao Y, Ma J, Bu H, Zhao YVitamin D on Cardiac Function in Heart Failure: A Systematic Review and Meta-Analysis of 10 RCTs.Rev Cardiovasc Med.(2023 Nov 1)
    26. Left Ventricular Ejection Fraction - Bharani A, Ganguly A, Bhargava KDSalutary effect of Terminalia Arjuna in patients with severe refractory heart failureInt J Cardiol.(1995 May)
    27. Left Ventricular Ejection Fraction - He S, Wang S, Xu T, Wang S, Qi M, Chen Q, Lin L, Wu H, Gan PRole of Thiamine Supplementation in the Treatment of Chronic Heart Failure: An Updated Meta-Analysis of Randomized Controlled Trials.Clin Cardiol.(2024 Jul 1)
    28. Mitochondrial Protection - Pam R Taub, Israel Ramirez-Sanchez, Theodore P Ciaraldi, Guy Perkins, Anne N Murphy, Robert Naviaux, Michael Hogan, Alan S Maisel, Robert R Henry, Guillermo Ceballos, Francisco VillarrealAlterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoaClin Transl Sci.(2012 Feb)
    29. Blood Flow - Andrew B. Petrone, J. Michael Gaziano, Luc DjousséEffects of Dark Chocolate and Cocoa Products on Endothelial Function: A Meta-AnalysisCurrent Nutrition Reports.()
    30. Heart Failure Risk - Fei Gong, Shuyuan Yao, Jing Wan, Xuedong GanChocolate Consumption and Risk of Heart Failure: A Meta-Analysis of Prospective StudiesNutrients.(2017 Apr 20)
    31. Heart Rate - Gomes ME, El Messaoudi S, Lenders JW, Bellersen L, Verheugt FW, Smits P, Tack CJHigh dose ascorbic acid does not reverse central sympathetic overactivity in chronic heart failureJ Clin Pharm Ther.(2011 Oct)
    32. Uric Acid - Abdollahi S, Vajdi M, Meshkini F, Vasmehjani AA, Sangsefidi ZS, Clark CCT, Soltani SResveratrol may mildly improve renal function in the general adult population: A systematic review and meta-analysis of randomized controlled clinical trials.Nutr Res.(2023-May)
    33. Risk of Hospitalization for Heart Failure - Dwiputra B, Ambari AM, Desandri DR, Purwowiyoto BS, Radi B, Pandhita BAW, Fatrin S, Santoso AThe Effect of Omega-3 Supplementation on Heart Failure Outcome: A Meta-Analysis of Randomized Clinical Trial.J Lipid Atheroscler.(2024 May)